GlassScriptPhysician profile
Benjamin Petrinec
NPI 1174101729
$7,426.81
in general payments reported to CMS, 2019-2025
10 companies · $4,391 in 2025
The $4,391 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,028 · 2024: $2,008 · 2025: $4,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,185 · Travel and Lodging: $3,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,184.87 |
| Travel and Lodging | $3,241.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,379.83 | 2023-2025 | Peristeen |
| Boston Scientific Corporation | $2,189.36 | 2023-2025 | Ams 700, Moses 550 Dfl, Ams 800 Artificial Urinary Sphincter |
| Olympus America INC. | $1,153.18 | 2023-2025 | Itind System |
| Photocure INC | $143.76 | 2024 | Cysview |
| Convatec INC. | $142.00 | 2025 | |
| Sumitomo Pharma America, INC. | $131.82 | 2023 | Orgovyx |
| Endo Pharmaceuticals INC. | $124.85 | 2023 | Xiaflex |
| Medtronic, INC. | $97.54 | 2023-2024 | Interstim |
| Antares Pharma, INC. | $50.00 | 2023 | Tlando, Xyosted |
| Ethicon US, LLC | $14.47 | 2025 | Echelon; Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Petrinec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.